|
Total properties:
17
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/03/2015
|
Application #:
|
13374351
|
Filing Dt:
|
12/22/2011
|
|
Publication #:
|
|
Pub Dt:
|
06/27/2013
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS INCLUDING RECOMBINANT B LYMPHOCYTE CELL LINE INCLUDING AN EXOGENOUSLY INCORPORATED NUCLEIC ACID EXPRESSING AN EXOGENOUS MEMBRANE IMMUNOGLOBULIN REACTIVE TO A FIRST ANTIGEN AND INCLUDING AN ENDOGENOUS GENE EXPRESSING AN ENDOGENOUS SECRETED IMMUNOGLOBULIN REACTIVE TO A SECOND ANTIGEN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/24/2015
|
Application #:
|
13374353
|
Filing Dt:
|
12/22/2011
|
|
Publication #:
|
|
Pub Dt:
|
06/27/2013
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS INCLUDING RECOMBINANT B LYMPHOCYTE CELL LINE INCLUDING AT LEAST ONE ENDOGENOUS GENE EXPRESSING AT LEAST ONE ENDOGENOUS MEMBRANE IMMUNOGLOBULIN REACTIVE TO A FIRST ANTIGEN AND INCLUDING AT LEAST ONE EXOGENOUSLY INCORPORATED NUCLEIC ACID EXPRESSING AT LEAST ONE EXOGENOUS SECRETED IMMUNOGLOBULIN REACTIVE TO A SECOND ANTIGEN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/07/2017
|
Application #:
|
13804224
|
Filing Dt:
|
03/14/2013
|
|
Publication #:
|
|
Pub Dt:
|
09/18/2014
| | | | |
|
Title:
|
Compositions, Methods, and Computer Systems Related to Making and Administering Modified T Cells
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
13826803
|
Filing Dt:
|
03/14/2013
|
|
Publication #:
|
|
Pub Dt:
|
09/18/2014
| | | | |
|
Title:
|
COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/22/2016
|
Application #:
|
13827960
|
Filing Dt:
|
03/14/2013
|
|
Publication #:
|
|
Pub Dt:
|
09/18/2014
| | | | |
|
Title:
|
COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/06/2016
|
Application #:
|
14549685
|
Filing Dt:
|
11/21/2014
|
|
Publication #:
|
|
Pub Dt:
|
07/23/2015
| | | | |
|
Title:
|
Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including an Exogenously Incorporated Nucleic Acid Expressing an Exogenous Membrane Immunoglobulin Reactive to a First Antigen and Including an Endogenous Gene Expressing an Endogenous Secreted Immunoglobulin Reactive to a Second Antigen
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/02/2017
|
Application #:
|
14549726
|
Filing Dt:
|
11/21/2014
|
|
Publication #:
|
|
Pub Dt:
|
03/19/2015
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS INCLUDING RECOMBINANT B LYMPHOCYTE CELL LINE INCLUDING AN EXOGENOUSLY INCORPORATED NUCLEIC ACID EXPRESSING AN EXOGENOUS MEMBRANE IMMUNOGLOBULIN REACTIVE TO A FIRST ANTIGEN AND INCLUDING AN ENDOGENOUS GENE EXPRESSING AN ENDOGENOUS SECRETED I
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/19/2017
|
Application #:
|
14549763
|
Filing Dt:
|
11/21/2014
|
|
Publication #:
|
|
Pub Dt:
|
05/28/2015
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS INCLUDING RECOMBINANT B LYMPHOCYTE CELL LINE INCLUDING AN EXOGENOUSLY INCORPORATED NUCLEIC ACID EXPRESSING AN EXOGENOUS MEMBRANE IMMUNOGLOBULIN REACTIVE TO A FIRST ANTIGEN AND INCLUDING AN ENDOGENOUS GENE EXPRESSING AN ENDOGENOUS SECRETED I
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/18/2016
|
Application #:
|
14623722
|
Filing Dt:
|
02/17/2015
|
|
Publication #:
|
|
Pub Dt:
|
07/30/2015
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS INCLUDING RECOMBINANT B LYMPHOCYTE CELL LINE INCLUDING AT LEAST ONE ENDOGENOUS GENE EXPRESSING AT LEAST ONE ENDOGENOUS MEMBRANE IMMUNOGLOBULIN REACTIVE TO A FIRST ANTIGEN AND INCLUDING AT LEAST ONE EXOGENOUSLY INCORPORATED NUCLEIC ACID EXPR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/27/2018
|
Application #:
|
14623759
|
Filing Dt:
|
02/17/2015
|
|
Publication #:
|
|
Pub Dt:
|
10/08/2015
| | | | |
|
Title:
|
Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including at Least One Endogenous Gene Expressing at Least One Endogenous Membrane Immunoglobulin Reactive to a First Antigen and Including at Least One Exogenously Incorporated Nucleic Acid Expressing at Least One Exogenous Secreted Immunoglobulin Reactive to a Second Antigen
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/19/2019
|
Application #:
|
15178715
|
Filing Dt:
|
06/10/2016
|
|
Publication #:
|
|
Pub Dt:
|
12/08/2016
| | | | |
|
Title:
|
Compositions and Methods Including Cytotoxic B Lymphocyte Cell Line Expressing Exogenous Membrane Immunoglobulin Different from Secreted Immunoglobulin
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/30/2017
|
Application #:
|
15290043
|
Filing Dt:
|
10/11/2016
|
|
Publication #:
|
|
Pub Dt:
|
02/02/2017
| | | | |
|
Title:
|
COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15498780
|
Filing Dt:
|
04/27/2017
|
|
Publication #:
|
|
Pub Dt:
|
08/10/2017
| | | | |
|
Title:
|
COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/18/2020
|
Application #:
|
15924898
|
Filing Dt:
|
03/19/2018
|
|
Publication #:
|
|
Pub Dt:
|
08/02/2018
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS FOR MODIFIED B CELLS EXPRESSING REASSIGNED BIOLOGICAL AGENTS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16205556
|
Filing Dt:
|
11/30/2018
|
|
Publication #:
|
|
Pub Dt:
|
03/28/2019
| | | | |
|
Title:
|
COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/23/2021
|
Application #:
|
16256222
|
Filing Dt:
|
01/24/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/23/2019
| | | | |
|
Title:
|
Compositions and Methods Including Cytotoxic B Lymphocyte Cell Line Expressing Exogenous Membrane Immunoglobulin Different from Secreted Immunoglobulin
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/24/2020
|
Application #:
|
16523664
|
Filing Dt:
|
07/26/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/21/2019
| | | | |
|
Title:
|
Compositions and Methods for Modified B Cells Expressing Reassigned Biological Agents
|
|
